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The incidence of retained placenta (RP) in cows increases in cases of parturition induced by prostaglandin F
2𝛼
. We analyzed the
effects of different doses of supplemental selenium and vitamin E on the incidence of RP, blood selenium, plasma thyronines, and
malondialdehyde concentration. Thirty-three clinically healthy, multiparous Holstein-Frisian cows were assigned to 3 groups and
supplemented with a single intramuscular injection of sodium selenite (SS) and tocopherol acetate (TAc) between days 250 to 255 of
gestation: control—unsupplemented; groupA—10mg SS + 400mgTAc; group B—20mg SS + 800mgTAc. Parturitionwas induced
using PGF
2𝛼
not before day 275 of gestation. The RP incidence was reduced from 66.7% in the control to 38.2 and 30.8% in groups
A and B, respectively. Blood selenium and glutathione peroxidase activity in treated groups were significantly higher compared
to control, with no significant difference between groups A and B. Plasma malondialdehyde in group B was significantly lower
than that in control and group A, while thyronines levels were not affected. Comparison of RP and non-RP cows, independently
of supplement treatment, revealed higher blood selenium and glutathione peroxidase activity and lower MDA and thyroxine in
non-RP animals, while triiodothyronine level did not differ.
1. Introduction
Induced parturition in cows may have several technolog-
ical and medical advantages over spontaneous delivery,
such as avoiding unattended night-time calving, providing
colostrum to the newborn in time, preventing dystocia
caused by relative fetal oversize, dealing with fetal defor-
mities, and hydroallantois [1]. Calving can be successfully




). It acts on the corpus luteum to cause luteolysis and
stops the production of progesterone. Time required from
treatment to calf delivery ranges from 24 to 72 hours, on
average 48 hours. However, the major problem arising from
this procedure is a dramatic rise in the incidence of retained
placenta (RP), up to 80% in some cases [2], although no other
serious harmful effects on cows and calves have been reported
[3].
Retained placenta (RP) is a reproductive disorder seen in
cows and water buffalos. It is characterized by the inability
of the animal to expel fetal membranes within 12 hours after
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parturition. Its incidence varies from 1.3 to 39.2% of overall
parturitions, resulting in serious economic losses in the dairy
industry throughout the world [4].
The etiology of RP is complex and not yet fully under-
stood. In the majority of cases, it is directly caused by a
disturbance of the prepartal loosening mechanism in the
placentomes [5]. Dystocia and abortion/stillbirth increase the
risk of RP. Furthermore, cows with RP are at high risk of
developing metritis and silent heat, resulting in prolonged
service period and low fertility rate [6, 7]. Various factors,
such as age, breed, heredity, environment, hormonal status,
nutrition, and immunity had been implied to contribute to
the development of RP. However, no single factor was suffi-
cient to provide a satisfactory explanation for the mechanism
underlying the development of this disorder [8].
It is well established that innate and acquired immune
defense mechanisms are lowest in the peripartum period
due to metabolic strain during pregnancy, calving, and
early lactation [9]. Two immune mechanisms had been
proposed to explain the detachment of the fetal membranes
during parturition. Both were based on the hypothesis that
upon parturition, when blood supply to the placenta begins
to cease, the placenta becomes a “foreign body” that the
maternal immune system must recognize, attack, and expel.
Gunnink [10] demonstrated that leukocytes were less able
to recognize cotyledon tissue harvested from cows with
RP compared non-RP. However, Kimura et al. [8] argued
that 3–8 hours needed to expel fetal membranes was a too
short time for lymphocytes to mount an effective rejection
process; hence, they focused on the role of innate immunity
mediated by neutrophils through their oxygen-dependent
killing capabilities.
Pregnancy in dairy cows is considered to induce oxidative
stress, which in turn can be a significant underlying factor
to dysfunctional host immune and inflammatory responses
that can increase the incidence of perinatal disorders during
the transition period [11, 12]. Wischral et al. [13] proposed a
pathway of RP development starting with an imbalance of
the antioxidant capacity, followed by a decrease in estrogen
production, resulting in decreased PGF
2𝛼
and accumulation
of arachidonic and linoleic acids in the placental tissue.
Therefore, it is necessary that the animal organism should
be able to maintain its antioxidative/oxidative processes in
balance during peripartal period.
Methods for quantifying oxidative stress mostly include
direct or indirect measures of antioxidants and oxidants,
or their metabolic products present in animal tissues. Mal-
ondialdehyde (MDA) is one of the several low-molecular
weight end-products that arise fromoxidative decomposition
of polyunsaturated fatty acids. MDA readily reacts with
thiobarbituric acid producing a red pigment that can be
measured spectrophotometrically [14].
Selenium is well established as one of the key elements in
the antioxidative defense of a living organism. In the active
form, it is incorporated in glutathione peroxidases (GPx), a
family of enzymes that use the reductive potential of glu-
tathione (GSH) to convert hydroperoxides to corresponding
alcohols [15]. According to Bernabucci et al. [16, 17], plasma
GPx activity in cows raises several days prior to parturition
and gradually declines afterwards, while in the erythrocytes,
the activity remains constant. Vitamin E is the main chain
breaking antioxidant residing within the cell membranes.
However, in its reaction with the peroxyl radicals vitamin
E produces hydroperoxides that are still toxic and must be
removed [18] by GPx, hence the functional interdependence
of selenium and vitamin E.
The first report on the relationship between Se and
vitamin E status of cows and retention of placenta was
published by Trinder et al. [19] drawing substantial attention
to this subject. Experiments conducted by Jaskowski [20]
and Wentink et al. [21] established a minimal selenium
concentration in cow’s blood plasma of 30 ng/mL, below
which the incidence of RP would significantly rise, namely,
from 5-6% to 20–22%. Preventive effects of different doses
of Se and/or vitamin E against RP prepartally supplemented
to cows, have been reported over the years by a number of
authors [20–25].
All three known types of iodothyronine deiodinases (ID),
enzymes which activate and/or inactivate thyronines through
deiodination, contain Se in the form of selenocysteine in
their catalytic sites. However, ID activities are not as tightly
linked to Se status as the activity of GPx [26]. Therefore,
serum thyroxine (T4) and triiodothyronine (T3) levels as well
as T4/T3 ratio may only be slightly affected by marginal Se
deficiency [27]. According to Nixon et al. [28] in dairy cows
the stage of lactation and season of the year have a strong
influence on changes in serum thyronines. Concentrations
are the lowest in early lactation, during winter and early
spring. Pethes et al. [29] reported that serums T4 and T3
concentrations in periparturient cows start to decrease 14
days prior to delivery and recover slowly within the first few
weeks after parturition.
High incidence of retained placenta, together with a
wide variability in the intervals between prostaglandin F
2𝛼
treatment and calf delivery, remains the primary limiting
factor for the practical use of PGF
2𝛼
in the synchronization
of parturition on dairy farms. The aim of this trial was to
determine to which extent a preparturient supplementation
with different doses of Se and vitamin E would influence the
incidence of RP, as well as selenium, MDA, and thyronines
status in cows treated with PGF
2𝛼
for the induction of
parturition.
2. Material and Methods
2.1. Experimental Groups and Treatments. Thirty-three (33)
Holstein-Frisian cows included in this investigation were
randomly distributed to 3 groups and supplemented with
sodium selenite (SS) and tocopherol acetate (TAc) as follows:
(i) Control group (𝑛 = 9) was not supplemented, and it
served as a negative control;
(ii) group A (𝑛 = 11) was supplemented 10mg SS and
400mg TAc;
(iii) group B (𝑛 = 13) was supplemented 20mg SS and
800mg TAc.
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The supplement was administered by a single intramus-
cular injection between days 250 and 255 of gestation; par-
turition was induced using a single intramuscular injection
of PGF
2𝛼
(2mL, 500 𝜇g of cloprostenol) not before day 275
of gestation; venous blood samples for analysis were taken 12
hours postpartum.
All animals were clinically healthy, multiparous, and
single calve, with no previous record of retained placenta or
other disorders.
2.2. Blood Se Concentration. Determination of selenium in
whole blood samples of cows was carried out using atomic
absorption spectrometry-hydride technique. Microwave
digestion was used for sample preparation. Samples of whole
blood (0.5 g) were accurately weighted using analytical
balance Denver Instrument, model TB-215D (Denver
Instruments, USA), transferred into Teflon microwave
vessels, and digested with 8mL of 69% nitric acid (Sigma-
Aldrich, USA) and 2mL of 30% hydrogen peroxide (Fluka
Analytical, USA). Microwave oven (Milestone, Germany,
model Touch control) was set to the following program:
temperature ramp from ambient temperature at 180∘C
followed by 15min of holding time and 20min of cooling
time. Digested samples were transferred to volumetric flasks
and diluted using 5M hydrochloric acid (Sigma-Aldrich,
USA) to the final volume of 25mL. Determination of
selenium concentration was carried out using SolAAr,
Series 4 spectrometer equipped with VP70 hydride module
and EC90 electrical furnace for precise temperature
control of the analytical cuvette (Thermo Electron, UK).
Measuring absorption at 196 nm was performed after SeH
4
formation in the hydride system with 5% NaBH
4
(J. T. Baker,
The Netherlands) and 0.6% NaOH (Merck, Germany).
Stabilization and baseline delay times were 40 and 60
seconds, respectively, and reading time was 7 seconds in
three replicates. Furnace was set to 900∘C.
Quantification of Se content was performed using five-
point calibration curve (10–40𝜇g/kg, including zero) of ref-
erence standard solutions (Merck, Germany). Quality control
was achieved using blank samples fortified in 20𝜇g/kg of Se
and certified reference material (BCR 189). Good linearity
was obtained from the calibration curve (𝑟 = 0.998), and the
measured concentration of the reference material was in the
range of the reference value.
2.3. Serum MDA Concentration. Serum MDA was mea-
sured using the spectrophotometric method introduced by
Andreeva et al. [30]. All chemicals were obtained from
Sigma-Aldrich. Briefly, a 3mL of 0.1% orthophosphoric
acid, 1mL of 0.6% thiobarbituric acid, and 0.1mL of 0.28%
hydrated ferrous sulfate solution were added to 0.3mL of
serum. The reaction mixture was heated in boiling water
for 60 minutes. The produced chromogen was extracted
with n-butyl alcohol (4mL). After centrifugation (2200×g,
10 minutes), the butanol layer was separated for spectropho-
tometric measurement at 535 nm.
2.4. Blood Glutathione Peroxidase (GPx) Activity. Glutathi-
one peroxidase activity wasmeasured inwhole blood samples
by the coupled test described by Gu¨nzler et al. [31]. All
chemicals were obtained from Sigma-Aldrich. Blood samples








in the samples reduces tertiary butyl hydroperoxide (TBH).
Glutathione (GSH) as the donor of hydrogen becomes oxi-
dized to GS-SG. In the second phase of this coupled reaction,
GS-SG is reduced to GSH by NADPH and glutathione
reductase (GR). Final concentrations of used reagents were
100mM phosphate buffer (pH 7.4), 4mM EDTA, 6mM
GSH, 0.375 IU/mLGR, 0.3mMNADPH and 1.575mMTBH.
Low concentration of TBH (under 2.32mM) as used in
this method determines only the activity of Se-dependent
GPx. The reduction of NADPH was followed for 3min at
366 nm using a Cecil Ce2021 spectrophotometer (UK) with
a Peltier thermostat unit. Absorbance (𝐴) values were taken
at 30 seconds intervals, and the results were expressed in
microkatals per liter (𝜇kat/L).
2.5. Serum T3 and T4 Concentrations. Concentrations of T3
and T4 were measured in heparinized plasma samples using
commercial standard RIA kits (INEP, Zemun). The assay is
based on the competition between unlabelled T3 and T4 and
a fixed quantity of 125l labeled T3 and T4 for a limited number
of binding sites on T3 and T4 specific antibodies (bound to
the tubes). Allowing a fixed amount of tracer and antibody to
react with different amounts of unlabelled ligand, the amount
of tracer bound by the antibodywill be inversely proportional
to the concentration of unlabelled ligand. Antigen-antibody
complex is bound to the tubes, and the supernatant is then
separated by decantation. Counting the radioactivity of the
bound phase enables a standard curve to be constructed and
samples to be quantified.
2.6. Statistical Analysis. Obtained results were arranged and
analyzed from two aspects: Table 1 displays experimental
results according to Se and vitamin E treatments as previously
described, and Table 2 displays the results according to the
absence/presence of retained placenta in cows, diagnosed
12 hours postpartum, independently from Se and vitamin
E treatment. Data are presented as means ± SD. Analy-
sis was performed using MS Excel 2007 and Graph Pad
Prism 5 statistical software packages.The differences between
experimental groups were analyzed using Student’s t-test.
A probability level 𝑃 < 0.05 was considered statistically
significant.
3. Results
The treatment of cows with 10mg sodium selenite (SS) and
400mg tocopherol acetate (TAc) reduced the incidence of
retained placenta from 66.7% in the control group to 38.2%
in group A, while treatment with 20mg SS and 800mg
TAc further reduced RP to 30.8% in group B (Table 1).
Blood selenium concentrations and GPx activities in both
treated groups (A or B) were significantly higher compared
to the control; however, there were no significant differences
between groups A and B. Blood plasma MDA content was
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Table 1: The effects of three different SS and TAc supplemental treatments (mean ± SD) on the incidence of RP, Se, MDA, and thyroid status








(𝜇kat/L) Plasma MDA (𝜇M) Plasma T3 (nM) Plasma T4 (nM)
Control (𝑛 = 9) 66.7 129 ± 18 91 ± 15 5.70 ± 0.94 1.67 ± 0.26 49 ± 17
Group A (𝑛 = 11) 38.2 163 ± 28∗∗ 182 ± 32∗∗∗ 4.59 ± 1.20∗ 1.53 ± 0.40 60 ± 13∗
Group B (𝑛 = 13) 30.8 188 ± 30∗∗∗ 186 ± 33∗∗∗ 3.95 ± 0.88∗∗∗ 1.14 ± 0.44∗∗ 43 ± 16
Compared to control (𝑡-test): ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001.
Table 2: Selenium, MDA, and thyroid status of cows without (non-RP) and with retained placenta (RP) 12 hours postpartum, independently
of SS and TAc supplemental treatment. Parturition was induced using prostaglandin F
2𝛼
.
RP status (number of animals) Blood Se (ng/mL) Blood GPx (𝜇kat/L) Plasma MDA (𝜇M) Plasma T3 (nM) Plasma T4 (nM)
Non-RP (𝑛 = 19) 176 ± 33 181 ± 34 4.68 ± 0.93 1.31 ± 0.41 42 ± 13
RP (𝑛 = 14) 138 ± 40∗ 133 ± 48∗∗ 5.32 ± 0.80∗∗ 1.37 ± 0.34 51 ± 11∗∗
Between groups (𝑡-test): ∗𝑃 < 0.05; ∗∗𝑃 < 0.01.
lowest in group B (3.95 ± 0.88 𝜇M), significantly lower than
both control (5.70 ± 0.94 𝜇M) and group A (4.59 ± 1.20 𝜇M).
Total plasma T4 levels were highest in group A (59.55 ±
13.00 nM) and lowest in groupB (43.2±16.2 nM), whilemean
T3 concentrations ranged from 1.1 ± 0.4 nM in group B to
1.7 ± 0.6 nM in control group.
Comparison between cows with and without the diag-
nosed RP (independently from SS and TAc treatment),
revealed the following (Table 2): cows with RP had signifi-
cantly lower blood Se content and GPx activity and higher
plasma MDA concentrations compared to those free of RP.
Plasma T3 did not differ significantly, while plasma T4
concentration was significantly higher in cows with RP.
4. Discussion
The primary aim of this study was to test the assumption
that prepartum supplementation of cows with Se and vitamin
E should exhibit the protective effect against the onset of
retained placenta in cows with prostaglandin F
2𝛼
induced
parturition in a similar fashion as in animals with sponta-
neous parturition. To our best knowledge, this is the first such
attempt; therefore, the only available frame of reference for
our data is the research done on animals with spontaneous
labour.
In cows supplemented with Se and vitamin E, 20 days
prior to parturition induced by PGF
2𝛼
, the incidence of
retained placenta was effectively halved, from 66.7% in the
control group to 38.2% and 30.8% in groups A and B, respec-
tively (Table 1). Similarly, Julien et al. [22] demonstrated that a
single 20-day prepartum injection of 50mg of sodium selenite
and 680 IU of 𝛼-tocopherol acetate effectively reduced the
incidence of RP from 51.2% in the control group of cows
to 8.8% in the treated group. Selenium alone was at least as
effective as a combination of selenium and vitamin E [23].
The higher the dose of selenium administered, the lower the
incidence of RP was registered [24]. In all these experiments,
the percentage of RP in herds was reduced to values close to
zero, while in our trial the lowest value remained at 30.8%.
Therefore, we estimate that further increase in Se dosage
would not produce a linear but rather asymptotic decrease in
RP incidence. One must always bear in mind that selenium
is very toxic. The supplement dosage should be considered
with great care, balancing between sufficient supply and
avoiding toxicity. Marked discrepancies in dose/effect ratios
described in the literature may be the result of different basal
Se status of animals, which is highly dependable on naturally
occurring Se levels in locally produced feedstuffs. According
to investigations conducted by Jovanovic´ et al. [32] in the
region surrounding the experimental farm, Se content in
cereals and hay ranged from 40 to 62 𝜇gSe/kg. These results
are considered to bemarginally deficient. Furthermore, as the
retention of placenta is known to be a multifactorial disorder,
our results demonstrate that certain effects of PGF
2𝛼
may
not fall into the domain of oxidant-antioxidant balance in
the body and cannot be overcome solely by the antioxidative
actions of Se and vitamin E.
Blood selenium concentration is considered to be a
good indicator of the long-term Se status in most animal
species. Selenium concentration was significantly elevated
(Table 1) in groups A (163 ± 28 ng/mL) and B (188 ±
30 ng/mL) supplemented with 10mg and 20mg sodium
selenite, respectively, compared to unsupplemented control
animals (129 ± 18 ng/mL). Cows suffering from retained
placenta (Table 2) had significantly lower (𝑃 < 0.05) blood
Se content (138 ± 40 ng/mL) compared to non-RP animals
(176 ± 33 ng/mL). Kommisrud et al. [33] collected blood
samples from 254 Se unsupplemented dairy herds in Norway
and found that their blood Se concentrations ranged from 60
to 120 ng/g and proposed the content of 100–150 ngSe/g as a
delimiting range below which a higher incidence of RP could
be expected. Blood selenium concentrations measured in
their study were slightly below the range of the values found
in unsupplemented cows in our experiment. This reflects
the fact that Norwegian crops are slightly more selenium
deficient [34] than those in the northern part of Serbia
[32]. However, both sets of data corroborate that the blood
concentration of 150 ngSe/mL could represent the bound-
ary between higher and lower probability for the onset of
RP.
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The activity of selenium-dependent glutathione peroxi-
dase (GPx) in the blood of dairy cows from groups A and
B (182 ± 32 and 186 ± 33 𝜇kat/L, resp.) was twice as high
as in the control (91 ± 15 𝜇kat/L); however, activities did not
significantly differ between groups A and B (Table 1). Blood
GPx activity was significantly lower in cows with RP than in
non-RP cows (Table 2). Comparable results were presented in
studies conducted by Wischral et al. [13] and Kankofer et al.
[35].
Plasma MDA concentrations were 5.70 ± 0.94 𝜇M in
control, 4.59 ± 1.20 𝜇M in group A, and 3.95 ± 0.88 𝜇M in
group B. MDA was significantly lower in treated animals
(𝑃 < 0.05 in group A and 𝑃 < 0.01 in group B) compared
to control (Table 1). However, all of these values are generally
substantially higher than those published by Wischral et al.
[13], Erisir et al. [36], and Kankofer et al. [37].We assume that
high levels of MDA may be due to elevated oxidative stress
caused by premature parturition induced by PGF
2𝛼
. Animals
with RP had significantly higher (𝑃 < 0.01) plasma MDA
than non-RP cows (Table 2), which is in accordance with the
findings of the above-mentioned authors.
Concentrations of plasma thyroid hormones, T4 and T3,
in our experiment (Table 1) were below those published by
Jovanovic´ et al. [27] for 12 months old heifers fed Se-adequate
feed but corresponded to the levels published by Pethes et
al. [29] and Djokovic´ et al. [38] for mature cows in late
pregnancy. However, T4 and T3 did not apparently depend
upon blood selenium supplementation of the animals. On the
other hand, plasma T4 was significantly higher in cows with
diagnosed RP, compared to non-RP (Table 2).
5. Conclusion
Our study demonstrated that in cows treated with single
intramuscular injection of 20mg sodium selenite and 800mg
tocopherol acetate three weeks prepartum there was a signif-
icant increase in plasma GPx activity and decrease in MDA
concentration. Consequently, incidence of retained placenta
in supplemented compared to nonsupplemented animals was
reduced in half.This indicates that oxidative stressmay be the
principal, but not the only, cause of increased RP in animals
with induced parturition. Further investigation is needed,
using reasonably higher supplement doses of antioxidants, to
show whether the incidence of RP can be brought to values














TAc: 𝛼-Tocopherol acetate (vitamin E).
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